Meningioma Clinical Trials in Atlanta, Georgia
6 recruitingAtlanta, Georgia
Showing 1–6 of 6 trials
Recruiting
Phase 2
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Intracranial Meningioma
RTOG Foundation, Inc.153 enrolled11 locationsNCT06955169
Recruiting
Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology124 enrolled781 locationsNCT02523014
Recruiting
Not Applicable
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
SchwannomaIntracranial NeoplasmGrade I Meningioma+4 more
Emory University70 enrolled1 locationNCT04278118
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain TumorBrain Tumor - MetastaticBrain Tumor, Recurrent+3 more
GT Medical Technologies, Inc.600 enrolled54 locationsNCT04427384
Recruiting
Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Grade 2 MeningiomaIntracranial Meningioma
NRG Oncology163 enrolled214 locationsNCT03180268
Recruiting
Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Grade II MeningiomaGrade III MeningiomaAtypical Meningioma+3 more
Northwestern University27 enrolled8 locationsNCT02847559